Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1991 1
1992 1
1994 1
1996 1
1997 1
1998 1
1999 1
2003 1
2008 1
2012 1
2016 2
2017 2
2018 2
2019 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Assessment of the Potential for Veverimer Drug-Drug Interactions.
Parsell D, Shao J, Guttendorf R, Mathur V, Li E, Wu YS, Tsao L, Tabakman S, Stasiv Y, Lee A, Biyani K, Klaerner G. Parsell D, et al. Among authors: guttendorf r. Drug Metab Dispos. 2021 Jul;49(7):490-500. doi: 10.1124/dmd.121.000366. Epub 2021 May 24. Drug Metab Dispos. 2021. PMID: 34031138 Clinical Trial.
Genetic aspects of drug disposition and therapeutics.
Guttendorf RJ, Wedlund PJ. Guttendorf RJ, et al. J Clin Pharmacol. 1992 Feb;32(2):107-17. doi: 10.1002/j.1552-4604.1992.tb03814.x. J Clin Pharmacol. 1992. PMID: 1613119 Review. No abstract available.
Pharmacokinetics of clinafloxacin enantiomers in humans.
Humphrey GH, Shapiro MA, Randinitis EJ, Guttendorf RJ, Brodfuehrer JI. Humphrey GH, et al. Among authors: guttendorf rj. J Clin Pharmacol. 1999 Nov;39(11):1143-50. J Clin Pharmacol. 1999. PMID: 10579144
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease.
Grundman M, Morgan R, Lickliter JD, Schneider LS, DeKosky S, Izzo NJ, Guttendorf R, Higgin M, Pribyl J, Mozzoni K, Safferstein H, Catalano SM. Grundman M, et al. Among authors: guttendorf r. Alzheimers Dement (N Y). 2019 Jan 23;5:20-26. doi: 10.1016/j.trci.2018.11.001. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 30723776 Free PMC article.
20 results